Gregory M. Weiss, M.D.

Gregory Weiss, MD, provides perspective on how improved safety of these procedures has revolutionized the way clinicians view use of bariatric and metabolic surgeries as a method for inducing weight loss in people with overweight and obesity.

In this column, Gregory Weiss, MD, reviews recent data suggesting lipid biomarkers could be used to identify patients at increased risk of developing diabetic neuropathy later in life.

In this column, Gregory Weiss, MD, provides perspective on a recent study providing evidence in support of metformin as a potential therapeutic option for treatment of atrial fibrillation.

Dr. Gregory Weiss provides perspective on data from the American Society for Metabolic and Bariatric Surgery 2022 Annual meeting suggesting patients who underwent bariatric surgery reduced their risk of cancer later in life.

Dr. Gregory Weiss discusses prediabetes screening in the US as a method help quell the growing diabetes epidemic in younger populations.

Dr. Gregory Weiss provides perspective on recent data detailing the potential for kidney damage as a result of long-term inhibition of the renin-angiotensin system.

A recent study published in the Journal of the American Society of Nephrology suggests patients with chronic kidney disease have little access to reliable information related to nutrition for patients with chronic kidney disease.

Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause.

In a recent column Gregory Weiss, MD, uses studies from AHA Scientific Sessions 2020 to compare the cost-effectiveness of antihyperglycemic agents for reducing cardiovascular events.

Empagliflozin shown to significantly reduce liver fat in patients with T2DM, according to a new study.